Long-Acting Injectables Market, Global Outlook and Forecast 2022-2028

April 2022 | 69 pages | ID: LA6F3ECBBED5EN
Market Monitor Global

Abstracts

Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks intervals.

This report contains market size and forecasts of Long-Acting Injectables in Global, including the following market information:

Global Long-Acting Injectables Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Long-Acting Injectables market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Small and Middle Sized Molecule Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Long-Acting Injectables include Eli Lilly, Pfizer, GlaxoSmithKline, Johnson & Johnson, Lupin, Zogenix, DURECT and Medincel, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Long-Acting Injectables companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Long-Acting Injectables Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Long-Acting Injectables Market Segment Percentages, by Type, 2021 (%)

• Small and Middle Sized Molecule
• Large Sized Molecule

Global Long-Acting Injectables Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Long-Acting Injectables Market Segment Percentages, by Application, 2021 (%)

• Schizophrenia
• Other Psychotic Disorders

Global Long-Acting Injectables Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Long-Acting Injectables Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Long-Acting Injectables revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Long-Acting Injectables revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly
• Pfizer
• GlaxoSmithKline
• Johnson & Johnson
• Lupin
• Zogenix
• DURECT
• Medincel

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Long-Acting Injectables Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Long-Acting Injectables Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LONG-ACTING INJECTABLES OVERALL MARKET SIZE

2.1 Global Long-Acting Injectables Market Size: 2021 VS 2028
2.2 Global Long-Acting Injectables Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Long-Acting Injectables Players in Global Market
3.2 Top Global Long-Acting Injectables Companies Ranked by Revenue
3.3 Global Long-Acting Injectables Revenue by Companies
3.4 Top 3 and Top 5 Long-Acting Injectables Companies in Global Market, by Revenue in 2021
3.5 Global Companies Long-Acting Injectables Product Type
3.6 Tier 1, Tier 2 and Tier 3 Long-Acting Injectables Players in Global Market
  3.6.1 List of Global Tier 1 Long-Acting Injectables Companies
  3.6.2 List of Global Tier 2 and Tier 3 Long-Acting Injectables Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Long-Acting Injectables Market Size Markets, 2021 & 2028
  4.1.2 Small and Middle Sized Molecule
  4.1.3 Large Sized Molecule
4.2 By Type - Global Long-Acting Injectables Revenue & Forecasts
  4.2.1 By Type - Global Long-Acting Injectables Revenue, 2017-2022
  4.2.2 By Type - Global Long-Acting Injectables Revenue, 2023-2028
  4.2.3 By Type - Global Long-Acting Injectables Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Long-Acting Injectables Market Size, 2021 & 2028
  5.1.2 Schizophrenia
  5.1.3 Other Psychotic Disorders
5.2 By Application - Global Long-Acting Injectables Revenue & Forecasts
  5.2.1 By Application - Global Long-Acting Injectables Revenue, 2017-2022
  5.2.2 By Application - Global Long-Acting Injectables Revenue, 2023-2028
  5.2.3 By Application - Global Long-Acting Injectables Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Long-Acting Injectables Market Size, 2021 & 2028
6.2 By Region - Global Long-Acting Injectables Revenue & Forecasts
  6.2.1 By Region - Global Long-Acting Injectables Revenue, 2017-2022
  6.2.2 By Region - Global Long-Acting Injectables Revenue, 2023-2028
  6.2.3 By Region - Global Long-Acting Injectables Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Long-Acting Injectables Revenue, 2017-2028
  6.3.2 US Long-Acting Injectables Market Size, 2017-2028
  6.3.3 Canada Long-Acting Injectables Market Size, 2017-2028
  6.3.4 Mexico Long-Acting Injectables Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Long-Acting Injectables Revenue, 2017-2028
  6.4.2 Germany Long-Acting Injectables Market Size, 2017-2028
  6.4.3 France Long-Acting Injectables Market Size, 2017-2028
  6.4.4 U.K. Long-Acting Injectables Market Size, 2017-2028
  6.4.5 Italy Long-Acting Injectables Market Size, 2017-2028
  6.4.6 Russia Long-Acting Injectables Market Size, 2017-2028
  6.4.7 Nordic Countries Long-Acting Injectables Market Size, 2017-2028
  6.4.8 Benelux Long-Acting Injectables Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Long-Acting Injectables Revenue, 2017-2028
  6.5.2 China Long-Acting Injectables Market Size, 2017-2028
  6.5.3 Japan Long-Acting Injectables Market Size, 2017-2028
  6.5.4 South Korea Long-Acting Injectables Market Size, 2017-2028
  6.5.5 Southeast Asia Long-Acting Injectables Market Size, 2017-2028
  6.5.6 India Long-Acting Injectables Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Long-Acting Injectables Revenue, 2017-2028
  6.6.2 Brazil Long-Acting Injectables Market Size, 2017-2028
  6.6.3 Argentina Long-Acting Injectables Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Long-Acting Injectables Revenue, 2017-2028
  6.7.2 Turkey Long-Acting Injectables Market Size, 2017-2028
  6.7.3 Israel Long-Acting Injectables Market Size, 2017-2028
  6.7.4 Saudi Arabia Long-Acting Injectables Market Size, 2017-2028
  6.7.5 UAE Long-Acting Injectables Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Eli Lilly
  7.1.1 Eli Lilly Corporate Summary
  7.1.2 Eli Lilly Business Overview
  7.1.3 Eli Lilly Long-Acting Injectables Major Product Offerings
  7.1.4 Eli Lilly Long-Acting Injectables Revenue in Global Market (2017-2022)
  7.1.5 Eli Lilly Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Long-Acting Injectables Major Product Offerings
  7.2.4 Pfizer Long-Acting Injectables Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline Long-Acting Injectables Major Product Offerings
  7.3.4 GlaxoSmithKline Long-Acting Injectables Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Long-Acting Injectables Major Product Offerings
  7.4.4 Johnson & Johnson Long-Acting Injectables Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Lupin
  7.5.1 Lupin Corporate Summary
  7.5.2 Lupin Business Overview
  7.5.3 Lupin Long-Acting Injectables Major Product Offerings
  7.5.4 Lupin Long-Acting Injectables Revenue in Global Market (2017-2022)
  7.5.5 Lupin Key News
7.6 Zogenix
  7.6.1 Zogenix Corporate Summary
  7.6.2 Zogenix Business Overview
  7.6.3 Zogenix Long-Acting Injectables Major Product Offerings
  7.6.4 Zogenix Long-Acting Injectables Revenue in Global Market (2017-2022)
  7.6.5 Zogenix Key News
7.7 DURECT
  7.7.1 DURECT Corporate Summary
  7.7.2 DURECT Business Overview
  7.7.3 DURECT Long-Acting Injectables Major Product Offerings
  7.7.4 DURECT Long-Acting Injectables Revenue in Global Market (2017-2022)
  7.7.5 DURECT Key News
7.8 Medincel
  7.8.1 Medincel Corporate Summary
  7.8.2 Medincel Business Overview
  7.8.3 Medincel Long-Acting Injectables Major Product Offerings
  7.8.4 Medincel Long-Acting Injectables Revenue in Global Market (2017-2022)
  7.8.5 Medincel Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Long-Acting Injectables Market Opportunities & Trends in Global Market
Table 2. Long-Acting Injectables Market Drivers in Global Market
Table 3. Long-Acting Injectables Market Restraints in Global Market
Table 4. Key Players of Long-Acting Injectables in Global Market
Table 5. Top Long-Acting Injectables Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Long-Acting Injectables Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Long-Acting Injectables Revenue Share by Companies, 2017-2022
Table 8. Global Companies Long-Acting Injectables Product Type
Table 9. List of Global Tier 1 Long-Acting Injectables Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Long-Acting Injectables Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Long-Acting Injectables Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Long-Acting Injectables Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Long-Acting Injectables Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Long-Acting Injectables Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Long-Acting Injectables Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Long-Acting Injectables Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Long-Acting Injectables Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Long-Acting Injectables Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Long-Acting Injectables Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Long-Acting Injectables Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Long-Acting Injectables Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Long-Acting Injectables Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Long-Acting Injectables Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Long-Acting Injectables Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Long-Acting Injectables Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Long-Acting Injectables Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Long-Acting Injectables Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Long-Acting Injectables Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Long-Acting Injectables Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Long-Acting Injectables Product Offerings
Table 32. Eli Lilly Long-Acting Injectables Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Long-Acting Injectables Product Offerings
Table 35. Pfizer Long-Acting Injectables Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Long-Acting Injectables Product Offerings
Table 38. GlaxoSmithKline Long-Acting Injectables Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Long-Acting Injectables Product Offerings
Table 41. Johnson & Johnson Long-Acting Injectables Revenue (US$, Mn), (2017-2022)
Table 42. Lupin Corporate Summary
Table 43. Lupin Long-Acting Injectables Product Offerings
Table 44. Lupin Long-Acting Injectables Revenue (US$, Mn), (2017-2022)
Table 45. Zogenix Corporate Summary
Table 46. Zogenix Long-Acting Injectables Product Offerings
Table 47. Zogenix Long-Acting Injectables Revenue (US$, Mn), (2017-2022)
Table 48. DURECT Corporate Summary
Table 49. DURECT Long-Acting Injectables Product Offerings
Table 50. DURECT Long-Acting Injectables Revenue (US$, Mn), (2017-2022)
Table 51. Medincel Corporate Summary
Table 52. Medincel Long-Acting Injectables Product Offerings
Table 53. Medincel Long-Acting Injectables Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Long-Acting Injectables Segment by Type in 2021
Figure 2. Long-Acting Injectables Segment by Application in 2021
Figure 3. Global Long-Acting Injectables Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Long-Acting Injectables Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Long-Acting Injectables Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Long-Acting Injectables Revenue in 2021
Figure 8. By Type - Global Long-Acting Injectables Revenue Market Share, 2017-2028
Figure 9. By Application - Global Long-Acting Injectables Revenue Market Share, 2017-2028
Figure 10. By Region - Global Long-Acting Injectables Revenue Market Share, 2017-2028
Figure 11. By Country - North America Long-Acting Injectables Revenue Market Share, 2017-2028
Figure 12. US Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Long-Acting Injectables Revenue Market Share, 2017-2028
Figure 16. Germany Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 17. France Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Long-Acting Injectables Revenue Market Share, 2017-2028
Figure 24. China Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 28. India Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Long-Acting Injectables Revenue Market Share, 2017-2028
Figure 30. Brazil Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Long-Acting Injectables Revenue Market Share, 2017-2028
Figure 33. Turkey Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Long-Acting Injectables Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly Long-Acting Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Long-Acting Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Long-Acting Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Long-Acting Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Lupin Long-Acting Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Zogenix Long-Acting Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. DURECT Long-Acting Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Medincel Long-Acting Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)